Asymptomatic cryptococcal antigenemia is associated with mortality among HIV‐positive patients in Indonesia. Issue 2 (28th January 2014)

• Record Type: Journal Article
• Authors: Ganiem, Ahmad Rizal; Indrati, Agnes Rengga; Wisaksana, Rudi; Meijerink, Hinta; van der Ven, Andre; Alisjahbana, Bachti; van Crevel, Reinout
• Is Part Of: Journal of the International AIDS Society. Volume 17:Issue 2 (2014)Supplement 1
• Page Start: n/a
• Page End: n/a
• Publication Date: 2014-01-28
• Subjects: cryptococcal antigenemia -- meningitis -- AIDS -- antigen testing -- lateral flow assay -- Indonesia; AIDS (Disease) -- Periodicals; HIV infections -- Periodicals; 616.9792005
• DOI: 10.7448/IAS.17.1.18821
• Languages: English
• ISSNs: 1758-2652

Abstract

Abstract : Introduction: Previous studies, mostly from Africa, have shown that serum cryptococcal antigenemia may precede the development of cryptococcal meningitis and early death among patients with advanced HIV infection. We examined cryptococcal antigenemia as a risk factor for HIV‐associated mortality in Indonesia, which is experiencing a rapidly growing HIV epidemic. Methods: We included ART‐naïve HIV patients with a CD4 cell count below 100 cells/μL and no signs of meningitis in an outpatient HIV clinic in Bandung, West Java, Indonesia. Baseline clinical data and follow‐up were retrieved from a prospective database, and cryptococcal antigen was measured in stored serum samples using a semiquantitative lateral flow assay. Cox regression analysis was used to identify factors related to mortality. Results: Among 810 patients (median CD4 cell count 22), 58 (7.1%) had a positive cryptococcal antigen test with a median titre of 1:80 (range: 1:1 to 1:2560). Cryptococcal antigenemia at baseline was strongly associated with the development of cryptococcal meningitis and early death and loss to follow‐up. After one year, both death (22.4% vs. 11.6%; p =0.016; adjusted HR 2.19; 95% CI 1.78–4.06) and the combined endpoint of death or loss to follow‐up (67.2% vs. 40.4%; p <0.001; adjusted HR 1.57; 95% CI 1.12–2.20) were significantly higher among patients with a positive cryptococcal antigen test. Conclusions: Cryptococcal antigenemia is common and clinically relevant among patients with advanced HIV in this setting. Routine screening for cryptococcal antigen followed by lumbar puncture and pre‐emptive antifungal treatment for those who are positive may help in reducing early mortality.